Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian W Bigger

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Journal of Inherited Metabolic Disease|April 16, 2010
Successful allogeneic bone marrow transplant for Niemann-Pick disease type C2 is likely to be associated with a severe 'graft versus substrate' effectDenise K Bonney, Anne O'Meara, Abdu Shabani, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2019
Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type IArunabha Ghosh, Aiyin Liao, Claire O'Leary, et al.
The Journal of Pediatrics|March 28, 2009
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapyRobert F Wynn, J Ed Wraith, Jean Mercer, et al.
Journal of Neurodevelopmental Disorders|February 7, 2015
An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-IIIElaine M Cross, Sheena Grant, Simon Jones, et al.
Nanomedicine (London, England)|December 20, 2019
Hampering brain tumor proliferation and migration using peptide nanofiber:si<i>PLK1</i>/<i>MMP2</i> complexesMariarosa Mazza, Hassan Ahmad, Marilena Hadjidemetriou, et al.
Plos One|October 27, 2011
Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field testAlex Langford-Smith, Kia J Langford-Smith, Simon A Jones, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2005
Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cellsElena K Siapati, Brian W Bigger, James Miskin, et al.
Free Radical Biology & Medicine|August 1, 2012
Analytical strategies for characterization of oxysterol lipidomes: liver X receptor ligands in plasmaWilliam J Griffiths, Peter J Crick, Yuchen Wang, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapyStuart Ellison, Aiyin Liao, Hélène F E Gleitz, et al.
Plos One|October 23, 2013
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrierKia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Inherited Metabolic Disease|April 16, 2010
Successful allogeneic bone marrow transplant for Niemann-Pick disease type C2 is likely to be associated with a severe 'graft versus substrate' effectDenise K Bonney, Anne O'Meara, Abdu Shabani, et al.
Molecular Therapy. Methods & Clinical Development|April 13, 2019
Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type IArunabha Ghosh, Aiyin Liao, Claire O'Leary, et al.
The Journal of Pediatrics|March 28, 2009
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapyRobert F Wynn, J Ed Wraith, Jean Mercer, et al.
Journal of Neurodevelopmental Disorders|February 7, 2015
An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-IIIElaine M Cross, Sheena Grant, Simon Jones, et al.
Nanomedicine (London, England)|December 20, 2019
Hampering brain tumor proliferation and migration using peptide nanofiber:si<i>PLK1</i>/<i>MMP2</i> complexesMariarosa Mazza, Hassan Ahmad, Marilena Hadjidemetriou, et al.
Plos One|October 27, 2011
Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field testAlex Langford-Smith, Kia J Langford-Smith, Simon A Jones, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2005
Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cellsElena K Siapati, Brian W Bigger, James Miskin, et al.
Free Radical Biology & Medicine|August 1, 2012
Analytical strategies for characterization of oxysterol lipidomes: liver X receptor ligands in plasmaWilliam J Griffiths, Peter J Crick, Yuchen Wang, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapyStuart Ellison, Aiyin Liao, Hélène F E Gleitz, et al.
Plos One|October 23, 2013
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrierKia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, et al.
Pageof 7